Thanks for that info Ohm. My original point is that the mortality rate is dependent on the patient population. Taking an ICU mortality of 34.7% which has mixed severe & critical patients (mostly critical) and applying it wholesale to all cd12 placebo which is also mixed and at ratios we don't know is a huge (and IMO unrealistic) assumption.